In this seminar, Praduman Jain, MS, founder and CEO of Vibrent Health, will provide information about how the National Center for Advancing Translational Sciences is looking to advance decentralized methods to support rural and remote settings, and expand the recruitment of minorities, women, and members from rural-based communities in clinical trials. To expand programs both scientifically and geographically, new digital tools and resources are needed to provide more diverse collaborative opportunities for innovation. These tools and resources need to be innovative, effective, scientifically based, and transformational whether digital, nondigital, or both.
Jain will talk about his experience with several research programs, small and large, that are utilizing these innovative, evidence-based digital tools and resources to conduct patient-powered/patient-centered precision research. These tools are scientifically proven and have been shown to reduce barriers to clinical research.
Jain will also talk about how the University of Maryland, Baltimore's Institute for Clinical and Translational Research (ICTR) can build capacity for successful pragmatic clinical trials, investigator-initiated studies, and industry clinical trials, through digital tools, training, and processes. Jain will highlight a few research programs such as the National Institutes of Health (NIH) All of Us, a large longitudinal study, that has successfully achieved high, multiyear retention through community engagement.
Register here for the seminar at noon Dec. 12: ICTR Enrichment Seminar: Dec. 12, 2023
More about Praduman Jain
Praduman Jain, known to colleagues as “PJ,” is the founder and CEO of Vibrent Health and the principal investigator (PI) of the NIH All of Us Research Program. Under Jain’s leadership, the NIH awarded Vibrent $75 million in 2017 and follow-on funding starting 2020 each year of $30 million to build and manage a national digital platform for biomedical research for 1 million people across the U.S. Jain is also a PI of the NIH AIM-AHEAD program and the NIH RADx TECH program to increase diversity in clinical research and trials.
Jain is an invited member of the National Academies of Sciences, Engineering, and Medicine’s Roundtable on Genomics and Precision Health. He earned MS and BS degrees in electrical engineering, holds several patents, and has authored several peer-reviewed papers in leading scientific journals.